KindlyMD (NASDAQ:NAKA – Get Free Report) and Kingsway Financial Services (NYSE:KWY – Get Free Report) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk.
Risk & Volatility
KindlyMD has a beta of 16.03, indicating that its stock price is 1,503% more volatile than the S&P 500. Comparatively, Kingsway Financial Services has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500.
Valuation and Earnings
This table compares KindlyMD and Kingsway Financial Services”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KindlyMD | $1.82 million | 59.18 | -$52.23 million | ($35.85) | -0.16 |
| Kingsway Financial Services | $134.97 million | 1.81 | -$10.73 million | ($0.30) | -28.13 |
Kingsway Financial Services has higher revenue and earnings than KindlyMD. Kingsway Financial Services is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings and target prices for KindlyMD and Kingsway Financial Services, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KindlyMD | 1 | 0 | 3 | 0 | 2.50 |
| Kingsway Financial Services | 1 | 0 | 0 | 0 | 1.00 |
KindlyMD presently has a consensus target price of $20.00, indicating a potential upside of 240.72%. Given KindlyMD’s stronger consensus rating and higher possible upside, equities research analysts plainly believe KindlyMD is more favorable than Kingsway Financial Services.
Profitability
This table compares KindlyMD and Kingsway Financial Services’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KindlyMD | -1,067.93% | -63.45% | -41.04% |
| Kingsway Financial Services | -6.53% | -67.61% | -4.43% |
Institutional and Insider Ownership
72.4% of Kingsway Financial Services shares are held by institutional investors. 24.1% of KindlyMD shares are held by company insiders. Comparatively, 41.4% of Kingsway Financial Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Kingsway Financial Services beats KindlyMD on 7 of the 13 factors compared between the two stocks.
About KindlyMD
KindlyMD, Inc. is a healthcare company focused on providing integrated care for patients dealing with chronic pain, behavioral health conditions and substance-use disorders. The company emphasizes a patient-centered approach that combines medical treatment, behavioral health support and other services designed to address the underlying factors affecting a patient’s health and quality of life. KindlyMD’s services include chronic pain evaluation and management, medication-assisted treatment for opioid-use disorder, behavioral health care and related primary or supportive healthcare services.
About Kingsway Financial Services
Kingsway Financial Services Inc. (NYSE:KWY) is a Canadian-based holding company that owns and operates businesses in the specialty insurance and insurance-services sectors. Its portfolio includes companies providing specialty insurance products, extended warranty programs, and related administrative and claims services. Historically, Kingsway operated primarily as a specialty insurance provider, including nonstandard automobile insurance businesses in the United States and Canada. The company has since focused on managing and developing a diversified group of insurance and non-insurance subsidiaries, with operations serving customers principally in North America.
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
